NDC 16729-095 – Quetiapine Fumarate
Quetiapine Fumarate 200 mg/1 · Tablet, Extended Release · Oral
Product NDC16729-095
Product details
- Brand name
- Quetiapine Fumarate
- Generic name
- Quetiapine Fumarate
- Labeler
- Accord Healthcare Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA090681
- Marketed since
- January 1, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Quetiapine Fumarate 200 mg/1
Uses, dosage, side effects and warnings for Quetiapine Fumarate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 16729-095-12 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-095-12) | Jan 1, 2019 |
Other Quetiapine Fumarate products
- 16729-109 Quetiapine Fumarate 150 mg/1 · Tablet, Extended Release · Accord Healthcare Inc.
- 16729-132 Quetiapine Fumarate 50 mg/1 · Tablet, Extended Release · Accord Healthcare Inc.
- 16729-097 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · Accord Healthcare Inc.
- 16729-096 Quetiapine Fumarate 300 mg/1 · Tablet, Extended Release · Accord Healthcare Inc.
- 50742-635 Quetiapine Fumarate 50 mg/1 · Tablet, Extended Release · Ingenus Pharmaceuticals, LLC
- 50742-637 Quetiapine Fumarate 200 mg/1 · Tablet, Extended Release · Ingenus Pharmaceuticals, LLC
- 50742-638 Quetiapine Fumarate 300 mg/1 · Tablet, Extended Release · Ingenus Pharmaceuticals, LLC
- 50742-639 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · Ingenus Pharmaceuticals, LLC
- 50742-636 Quetiapine Fumarate 150 mg/1 · Tablet, Extended Release · Ingenus Pharmaceuticals, LLC
- 34908-636 Quetiapine Fumarate 150 mg/1 · Tablet, Extended Release · Novast Laboratories, Ltd.
- 34908-639 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · Novast Laboratories, Ltd.
- 34908-637 Quetiapine Fumarate 200 mg/1 · Tablet, Extended Release · Novast Laboratories, Ltd.